- Service Name
Autoimmune Brain Panel™
- Industry
Healthcare, biotechnology, precision medicine, clinical laboratory services
- Main Value Proposition
The primary value offered is the ability to identify and treat neuropsychiatric symptoms stemming from autoimmune dysfunction, potentially leading to significant improvements in patient outcomes.
- Description
The Autoimmune Brain Panel™ is a series of high-complexity blood tests designed to assist clinicians in identifying whether neuropsychiatric symptoms are due to an underlying autoimmune response. This innovative testing approach aims to uncover the root causes of various neurologic and psychiatric disorders.
- Key Features
Antineuronal antibody testing; High complexity metabolic testing; Utilized by over 2,500 clinicians worldwide; Focus on immune-mediated neuropsychiatric disorders
- Use Cases
Primary scenarios where the service is most valuable include diagnosing treatment-resistant neuropsychiatric symptoms, guiding tailored treatment plans, and providing insights into autoimmune-related conditions.
- Competitive advantages
Unique focus on autoimmune causes of neuropsychiatric symptoms; Comprehensive testing based on over two decades of research; Integration of advanced technology for diagnosis and treatment
- Strengths
Key strengths include a robust scientific foundation, a unique testing approach that addresses previously undiagnosed conditions, and a commitment to improving patient care through precision medicine.
- Positioning
The service positions itself as a leader in precision medicine, focusing on uncovering immune-mediated causes of chronic disorders rather than merely treating symptoms.
- Audience
The target users include healthcare providers, patients with treatment-resistant neuropsychiatric symptoms, and researchers in the field of autoimmune disorders.
- Brand Positioning
Moleculera Biosciences is positioned as a pioneering company in precision medicine, dedicated to transforming patient care through innovative testing and treatment strategies.
- CTA
Order The Panel
- Differentiation
The Autoimmune Brain Panel™ is the only commercially available test of its kind that assists clinicians in diagnosing and treating immune-mediated neuropsychiatric disorders, setting it apart from traditional psychiatric assessments.
- Tagline
Transforming care with precision medicine.
- Tags
Autoimmune testing
Neuropsychiatric disorders
Precision medicine
Clinical laboratory
- Tone of Voice
Innovative, compassionate, authoritative
- Founded
2011-01-01
- Founders
Craig Shimasaki
Madeleine Cunningham